scholarly article | Q13442814 |
P50 | author | Takashi Ebihara | Q56514623 |
Miwa Sasai | Q79102033 | ||
P2093 | author name string | Misako Matsumoto | |
Tsukasa Seya | |||
Hiroyuki Tsutsumi | |||
Masashi Shingai | |||
Hisashi Ogura | |||
Masahiro Azuma | |||
Kenji Funami | |||
Minoru Ayata | |||
P2860 | cites work | SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK | Q24310727 |
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction | Q24318426 | ||
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates | Q27861007 | ||
5'-Triphosphate RNA is the ligand for RIG-I | Q28131726 | ||
VISA is an adapter protein required for virus-triggered IFN-beta signaling | Q28131814 | ||
TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway | Q28505835 | ||
Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling | Q28646137 | ||
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF | Q29547901 | ||
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling | Q29615457 | ||
Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection | Q30442832 | ||
Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. | Q33737766 | ||
The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin | Q33863111 | ||
TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. | Q34266420 | ||
Paramyxovirus accessory proteins as interferon antagonists | Q34525284 | ||
NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction | Q34586735 | ||
MDA5/RIG-I and virus recognition. | Q34749821 | ||
New aspects of IFN-alpha/beta signalling in immunity, oncogenesis and bone metabolism | Q35161743 | ||
Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells | Q35575961 | ||
Pathogenesis of respiratory syncytial virus infection | Q35848350 | ||
Function of RIG-I-like receptors in antiviral innate immunity | Q36774929 | ||
TLR3: interferon induction by double-stranded RNA including poly(I:C). | Q37080631 | ||
Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation | Q39600664 | ||
Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. | Q40079034 | ||
Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells | Q40208138 | ||
Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells | Q40327372 | ||
Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction | Q40446857 | ||
Recombinant respiratory syncytial virus lacking secreted glycoprotein G is attenuated, non-pathogenic but induces protective immunity | Q40513366 | ||
TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction | Q40675827 | ||
Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions | Q40830605 | ||
Polymorphism and proteolytic fragments of granulocyte membrane cofactor protein (MCP, CD46) of complement | Q41643574 | ||
Type I interferon regulates respiratory virus infected dendritic cell maturation and cytokine production | Q45398132 | ||
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus | Q45739890 | ||
Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community | Q45753705 | ||
Respiratory syncytial virus-induced cytokine production by neonatal macrophages | Q45765636 | ||
The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling | Q50335839 | ||
P433 | issue | 9 | |
P921 | main subject | modulation by virus of host process | Q14818042 |
toll-like receptor | Q408004 | ||
respiratory syncytial virus | Q1052913 | ||
P304 | page(s) | 1169-1180 | |
P577 | publication date | 2008-07-08 | |
P1433 | published in | International Immunology | Q15710043 |
P1476 | title | Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction | |
P478 | volume | 20 |
Q37252613 | A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice |
Q38130514 | Advances in and the potential of vaccines for respiratory syncytial virus |
Q35893983 | An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice |
Q36255118 | CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. |
Q92733658 | Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection |
Q34396689 | Current concepts and progress in RSV vaccine development. |
Q34282702 | Decreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infection |
Q26865337 | Dendritic cells in human Pneumovirus and Metapneumovirus infections |
Q26991548 | Development of asthma is determined by the age-dependent host response to respiratory virus infection: therapeutic implications |
Q115694808 | Functional Features of the Respiratory Syncytial Virus G Protein |
Q38267482 | Gene sequence variability of the three surface proteins of human respiratory syncytial virus (HRSV) in Texas |
Q116189036 | How RSV Proteins Join Forces to Overcome the Host Innate Immune Response |
Q39532133 | Human metapneumovirus glycoprotein G inhibits TLR4-dependent signaling in monocyte-derived dendritic cells |
Q52649839 | Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus. |
Q34180049 | Innate immune recognition of respiratory syncytial virus infection |
Q21710678 | Manipulation of dendritic cell function by viruses |
Q39154023 | Modulation of the host immune response by respiratory syncytial virus proteins |
Q40301155 | Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective |
Q38539476 | New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus. |
Q35943669 | Paramyxovirus fusion and entry: multiple paths to a common end |
Q33813095 | Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus |
Q37989884 | Prophylactic and therapeutic implications of toll-like receptor ligands |
Q34262180 | Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice |
Q36994716 | RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response. |
Q28548423 | RSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In Vivo |
Q39929993 | Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15). |
Q41838015 | Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses |
Q36935746 | Respiratory syncytial virus infection modifies and accelerates pulmonary disease via DC activation and migration |
Q33738914 | Respiratory syncytial virus infection reduces lung inflammation and fibrosis in mice exposed to vanadium pentoxide |
Q91526095 | Respiratory syncytial virus reduces STAT3 phosphorylation in human memory CD8 T cells stimulated with IL-21 |
Q36486630 | Respiratory syncytial virus regulates human microRNAs by using mechanisms involving beta interferon and NF-κB. |
Q39198689 | Respiratory syncytial virus-Host interaction in the pathogenesis of bronchiolitis and its impact on respiratory morbidity in later life. |
Q45358034 | Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication |
Q38696909 | The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection |
Q37263779 | The host response and molecular pathogenesis associated with respiratory syncytial virus infection |
Q37585325 | The regulation of type I interferon production by paramyxoviruses. |
Q37805072 | The role of cytokines and chemokines in severe respiratory syncytial virus infection and subsequent asthma |
Q34603346 | Therapeutic targeting of respiratory syncytial virus G-protein. |
Q33744060 | Within-host whole-genome deep sequencing and diversity analysis of human respiratory syncytial virus infection reveals dynamics of genomic diversity in the absence and presence of immune pressure |
Search more.